NEW YORK (360Dx) – Rapid point-of-care diagnostics firm POC Medical Systems today announced it raised $21 million in a Series A funding round.

The funds will go toward clinical beta testing and initial commercialization of a rapid, portable breast cancer screening test, MammoAlert, which is based on the firm's Pandora CDx microfluidics-based platform.

The blood-based test will enable breast cancer screening in regions where screening methods are not accessible to many woman, such as India where POC will initially launch MammoAlert.